Nov 6 (Reuters) - Immutep Ltd (IMM) :
- IMMUTEP ANNOUNCES COMPLETION OF THE SAFETY LEAD-IN AND OPENING OF THE RANDOMIZED PHASE II OF THE AIPAC-003 PHASE II/III TRIAL IN METASTATIC BREAST CANCER
- IMMUTEP LTD - GOOD SAFETY PROFILE ALLOWS FOR LEAD-IN PHASE TO BE CLOSED EARLY AND RANDOMIZED PHASE II PORTION OF STUDY WILL NOW PROCEED
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.010(4.17%) |
Mkt cap ! $337.6M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 23.0¢ | $244.5K | 1.043M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 392012 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 126850 | 6 |
View Market Depth
| Last trade - 16.10pm 12/09/2025 (20 minute delay) ? |
| IMM (ASX) Chart |